Table 2.
Genomic features of twenty SARS-CoV-2 clinical samples.
| S.No. | Patient ID | Qbit 4.O Reading ng/ul-RNA Sample | GenBank Accession No. | GISAID Accession No. | No. of Mapped Reads | Total Assigned Amplicon Reads | % on Target Reads | Average Read per Amplicon | Mean Depth | %Uniformity | Assembly Length (bp) | PANGO Lineage | Emerging Clade | GISAID Clade |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCOV/AB/21/FL407 | 3.02 | MZ562746 | EPI_ISL_1972141 | 1,378,010 | 1,364,626 | 99.03 | 5758 | 7503 | 74.30% | 29,837 | B.1.617.1 | 21B (Kappa) | G |
| 2 | NCOV/AB/21/FL409 | 8.87 | MZ562747 | EPI_ISL_1972134 | 3,733,707 | 3,732,055 | 99.96 | 15,747 | 25,230 | 97.89% | 29,833 | B.1.617.1 | 21B (Kappa) | G |
| 3 | NCOV/AB/21/FL901 | 5.92 | MZ562748 | EPI_ISL_1972135 | 2,389,121 | 2,388,613 | 99.98 | 10,079 | 15,986 | 97.03% | 29,834 | B.1.617.1 | 21B (Kappa) | G |
| 4 | NCOV/AB/21/FL902 | 5.53 | MZ562749 | EPI_ISL_1972136 | 2,725,685 | 2,694,642 | 98.86 | 11,370 | 18,478 | 99.29% | 29,840 | B.1.617.1 | 21B (Kappa) | G |
| 5 | NCOV/AB/21/FL832 | 6.73 | MZ562750 | EPI_ISL_1972130 | 661,367 | 144,412 | 21.84 | 609.3 | 936.4 | 99.28% | 29,816 | B.1.1.7 | 20I/501Y.V1 | GRY |
| 6 | NCOV/AB/21/FL405 | 3.72 | MZ562751 | EPI_ISL_1972142. | 3,581,768 | 3,544,684 | 98.96 | 14,956 | 22,246 | 97.10% | 29,826 | B.1.36 | 20A | GH |
| 7 | NCOV/AB/21/EX986 | 3.24 | MZ723921 | EPI_ISL_3305853 | 394,294 | 371,849 | 94.31 | 1569 | 2,473 | 97.28% | 29,800 | B.1.36 | 20A | GH |
| 8 | NCOV/AB/20/CA052 | 5.65 | MZ562752 | EPI_ISL_1972143 | 4,349,146 | 4,289,977 | 98.64 | 18,101 | 28,961 | 99.54% | 29,834 | B.1.36 | 20A | GH |
| 9 | NCOV/AB/21/FA012 | 6.69 | MZ562753 | EPI_ISL_1972144 | 1,506,394 | 1,446,477 | 96.02 | 6103 | 9750 | 99.49% | 29,848 | B.1.36 | 20A | GH |
| 10 | NCOV/AB/21/FB757 | 3.73 | MZ562754 | EPI_ISL_1972145 | 4,124,452 | 4,104,495 | 99.52 | 17,319 | 26,603 | 96.98% | 29,834 | B.1.36 | 20A | GH |
| 11 | NCOV/AB/21/FD308 | 3.88 | MZ562755 | EPI_ISL_1972146 | 80,774 | 79,290 | 98.16 | 334.6 | 534.7 | 99.12% | 29,834 | B.1.36 | 20A | GH |
| 12 | NCOV/AB/21/FF663 | 3.38 | MZ562756 | EPI_ISL_1972137 | 393,314 | 275,581 | 70.07 | 1163 | 1,842 | 98.12% | 29,833 | B.1.617.1 | 21B (Kappa) | G |
| 13 | NCOV/AB/21/FF945 | 4.34 | MZ562757 | EPI_ISL_1972138 | 2,080,768 | 2,058,700 | 98.94 | 8686 | 13,990 | 98.64% | 29,836 | B.1.617.1 | 21B (Kappa) | G |
| 14 | NCOV/AB/21/EQ324 | 5.32 | MZ562758 | EPI_ISL_1972139 | 917,154 | 899,993 | 98.13 | 3797 | 5,763 | 97.97% | 29,832 | B.1.617.1 | 21B (Kappa) | G |
| 15 | NCOV/AB/21/FG788 | 3.34 | MZ562759 | EPI_ISL_1972140 | 3,939,432 | 3,917,148 | 99.43 | 16,528 | 26,628 | 98.21% | 29,835 | B.1.617.1 | 21B (Kappa) | G |
| 16 | NCOV/AB/21/FK354 | 7.18 | MZ562760 | EPI_ISL_1972147 | 1,945,720 | 1,901,249 | 97.71 | 8022 | 12,758 | 99.11% | 29,853 | B.1.36 | 20A | GH |
| 17 | NCOV/AB/21/FL862 | 4.35 | MZ723922 | EPI_ISL_1972132 | 3,313,340 | 3,203,191 | 96.68 | 13,516 | 21,669 | 97.89% | 29,823 | B.1.1.7 | 20I/501Y.V1 | GRY |
| 18 | NCOV/AB/21/FK940 | 4.94 | MZ562761 | EPI_ISL_1972133 | 2,262,299 | 2,261,261 | 99.95 | 9541 | 14,961 | 99.10% | 29,840 | B.1.617.1 | 21B (Kappa) | G |
| 19 | NCOV/AB/21/FL880 | 5.27 | MZ562762 | EPI_ISL_1972131 | 2,668,661 | 2,667,095 | 99.94 | 11,254 | 18,319 | 99.06% | 29,817 | B.1.1.7 | 20I/501Y.V1 | GRY |
| 20 | NCOV/AB/21/FL414 | 6.54 | MZ734487 | EPI_ISL_3316398 | 238,608 | 125,526 | 52.61 | 529.6 | 848 | 92.73% | 29,834 | B.1.306 | 20B | GR |